Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-14 · accession 0001104659-22-046158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-14 | 2022-04-14 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir, 10% | M - OptEx | $1.89 | +34.1K | 537.8K | +7% | +$64.4K |
| D | 2022-04-14 | 2022-04-14 | PTGX | PATEL DINESH V PH D | Pres, CEO, Dir, 10% | M - OptEx | $0.00 | -34.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | M | A | 34,087 | $1.89 | 537,847 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-04-14 | M | D | 34,087 | $0.00 | 0 | D | $1.89 · — to 2024-10-22 | 34,087 Common Stock | (F1) The stock option is vested in full. |